Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Couch

Showing results (341-350 of 697) with videos related to

Pageof 70
Sort By:
Cancer Research|December 18, 2015
Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of DiseaseStephen J Murphy, Steven N Hart, Geoffrey C Halling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Journal of Personalized Medicine|June 26, 2015
Phenotype-Driven Plasma Biobanking Strategies and MethodsErica A Bowton, Sarah P Collier, Xiaoming Wang, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A ReappraisalJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
American Journal of Human Genetics|March 27, 2026
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variantsMarcy E Richardson, Megan Holdren, Terra Brannan, et al.
Clinical Breast Cancer|November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic ExperienceNusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Cancer Research|November 3, 2006
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer riskXianshu Wang, Fengwei Wang, Ken Taniguchi, et al.
Pageof 70

Showing results (341-350 of 697) with videos related to

Sort By:
Pageof 70
Cancer Research|December 18, 2015
Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of DiseaseStephen J Murphy, Steven N Hart, Geoffrey C Halling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Journal of Personalized Medicine|June 26, 2015
Phenotype-Driven Plasma Biobanking Strategies and MethodsErica A Bowton, Sarah P Collier, Xiaoming Wang, et al.
Breast Cancer Research and Treatment|March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristicsMegan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2019
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsHolly LaDuca, Eric C Polley, Amal Yussuf, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A ReappraisalJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
American Journal of Human Genetics|March 27, 2026
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variantsMarcy E Richardson, Megan Holdren, Terra Brannan, et al.
Clinical Breast Cancer|November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic ExperienceNusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Cancer Research|November 3, 2006
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer riskXianshu Wang, Fengwei Wang, Ken Taniguchi, et al.
Pageof 70